Page results
-
Winning the award - Sarcoma Healthcare Professionals Innovation and Excellence – CNS London Sarcoma Service, The National Sarcoma Educational Programme. Jo and Anne had the vision of sharing a regular in-house education session to bring sarcoma nurses and doctors together. These monthly sessions have seen a broad range of speakers and experts in the sarcoma field from other sarcoma units, charities and researchers sharing their knowledge.
-
UCLH is to trial the COVID-19 vaccine developed by University of Oxford in healthy staff volunteers.
-
Elective Placements and visiting doctors at The Hospital for Tropical Diseases
-
In his darkest moments, coronavirus patient Ertan Nazim feared he wouldn’t live to celebrate his 44th wedding anniversary.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
The huge impact the COVID-19 crisis is having on our patients and staff was the focus of a BBC News report broadcast tonight (Sunday).
-
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
-
ERCP (Endoscopic Retrograde Cholangiopancreatography) - UCLH patient information
-
During this time of visiting restrictions, we have introduced "Letters To Loved Ones" at UCLH.
-
The designs of a new breathing aid developed by engineers at UCL and Formula One working with clinicians at UCLH have been made freely available to support the global response to Covid-19.
File results
-
FOI/2024/0078 - Locally employed doctors at Trust
-
FOI/2024/0081 - Consultant doctors headcount
-
FOI/2024/0092 - Decision to cease Salvage RARP with nerve spare in 2023
-
FOI/2024/0095 - Hospital at home - Discharge and discharge to assess pathways
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023
-
FOI/2024/0140 - Operations cancelled due to low levels of staffing 2019-2023
-
FOI/2024/0147 - Permits to Work
-
FOI/2024/0151 - A&E decision-to-admit wait times 2019-2023